
The convergence of technological advances with a heightened demand for personalized, flexible approaches to care, forms the basis for the future of life sciences.
Connie Baumgard, MSN, is director of U.S. medical affairs at Abbott’s vascular business

The convergence of technological advances with a heightened demand for personalized, flexible approaches to care, forms the basis for the future of life sciences.